While mRNA expression of dopamine receptor D1 subtype (DRD1) exhibited a significant increase in patients with PD (Fig. 6b), mRNA expression of D2 subtype (DRD2) remained unaltered (Fig. 6c). The gene discussed is DRD2; the disease is Parkinson disease.